Clinical trial Recruiting at 3 sites Interventional Ages 18 to 60

Combining rTMS and Cognitive Therapy for Combat-related PTSD

Official title: Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Run by The University of Texas at Dallas · NCT03932773 · Data updated 2026-11-12

This study is testing whether combining a brain treatment called rTMS with therapy can help veterans with combat-related PTSD feel better.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment330 (estimated)
SponsorThe University of Texas at Dallas
Academic / other
Locations3 sites (Tallahassee, Florida and 2 other locations)
StatusRecruiting
StartedMay 1, 2019
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedAugust 20, 2026
Trial IDNCT03932773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are veterans of Post-9/11 military conflicts diagnosed with PTSD.

Probably not a fit

Patients currently enrolled in acute experimental treatments for PTSD or those with certain neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of combining repetitive Transcranial Magnetic Stimulation (rTMS) with Cognitive Processing Therapy (CPT) to treat combat-related Posttraumatic Stress Disorder (PTSD) in veterans. Participants will be randomly assigned to one of three treatment arms: active rTMS followed by CPT, sham rTMS followed by CPT, or rTMS alone. The study will assess changes in PTSD symptoms, depression, psychosocial functioning, and neurophysiological measures through various assessments at multiple time points. The goal is to determine the most effective treatment approach for alleviating PTSD symptoms.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce PTSD symptoms in veterans, improving their overall quality of life.

How similar studies have gone: Previous studies have shown promise in using rTMS for PTSD, but this specific combination approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Veterans of Post-9/11 military conflicts
* with diagnosis of PTSD based on CAPS-5 related to Post-9/11 military combat

Exclusion Criteria:

* current enrollment in an acute experimental treatment for PTSD or trauma-focused psychotherapy treatment
* PTSD-inducing trauma exposure occurring within the last 3 months prior to pre-enrollment evaluation
* history of epilepsy or seizure disorder, a history of major head trauma,
* any neurologic condition likely to increase risk of seizures,
* brain tumors,
* moderate to severe substance use disorder in last 3 months or any substance use that puts the participant at increased risk or significant impairment
* stroke, and blood vessel abnormalities in the brain,
* dementia,
* Parkinson's disease, Huntington's chorea, or multiple sclerosis
* a high suicide risk
* a lifetime history of psychotic disorder or bipolar disorder
* inability to stop taking any medication that significantly lowers the seizure threshold
* pregnant or nursing
* metal fragments in the head, or any metal objects in or near the head that cannot be safely removed
* We will screen for a history of traumatic brain injury and exclude potential participants from the study if they have a history of severe TBI or are at high risk for seizures.
* history of seizures
* non-English speakers because not all of the screening forms, questionnaires, and tests are available in any language except for English
* cardiac pacemaker, implanted medication pumps of any sort that would increase the risk of rTMS
* any current medical condition that could preclude being able to safely participate in TMS treatment,
* use of prescription medication or illegal substances that lower the seizure threshold
* previous rTMS

Where it's running

  • Florida State University College of Medicine
    Tallahassee, Florida, United States
    Recruiting
  • Metrocare Services of Dallas
    Addison, Texas, United States
    Recruiting
  • The University of Texas at Dallas
    Dallas, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: John Hart, Jr., MD — The University of Texas at Dallas
  • Study coordinator: Elizabeth "Ellen" Morris, PhD
  • Email: neurolab@utdallas.edu
  • Phone: 214-883-3171

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Anger, Social Thinking, and PTSD in French Veterans

    This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

    Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

  • TSND-201 treatment for PTSD in adults

    This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

    Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

  • Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

    This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

    Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

  • SEE FAR CBT for Adults With PTSD

    This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.

    Recruiting Community Stress Prevention Center · Kiryat Shmona · NCT07720674

  • Brief SEE FAR CBT: a short, focused therapy for adults with PTSD

    A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.

    Recruiting Community Stress Prevention Center · Sha'ar Hanegev · NCT07710573

  • MDMA Therapy for PTSD in Veterans

    This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.

    Recruiting Phase 2 Sunstone Medical · Rockville, Maryland · NCT07569159

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.